Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06529497

Racecadotril Versus Standard Treatment in Decreasing the Duration of Acute Diarrhoea in Children

Efficacy of Racecadotril in Addition to Standard Treatment i in Decreasing the Duration of Acute Diarrhoea in Children as Compared to Standard of Treatment Alone

Status
Not Yet Recruiting
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
260 (estimated)
Sponsor
Liaquat National Hospital & Medical College · Academic / Other
Sex
All
Age
3 Months – 5 Years
Healthy volunteers
Not accepted

Summary

Acute watery diarrhea is defined as the passage of 3 or more loose or liquid stools per day for 3 or more days but less than 14 days, including patients with mild to moderate dehydration per WHO classification. The study's outcome variables are stool frequency, measured by the total number of stools passed during 24 and 48 hours from the initiation of treatment, and hospital duration, measured by the total duration of hospital stay in hours. The null hypothesis states that racecadotril combined with standard treatment has no effect on reducing the mean number of stools passed during 48 hours compared to standard treatment alone in pediatric patients with acute watery diarrhea, while the alternate hypothesis suggests that racecadotril combined with standard treatment will significantly reduce the mean number of stools passed during 48 hours compared to standard treatment alone in these patients.

Conditions

Interventions

TypeNameDescription
DRUGRacecadotrilThe intervention group will receive racecadotril+ORS+Zinc

Timeline

Start date
2024-08-02
Primary completion
2024-11-15
Completion
2024-12-02
First posted
2024-07-31
Last updated
2024-07-31

Source: ClinicalTrials.gov record NCT06529497. Inclusion in this directory is not an endorsement.